Hyperhidrosis Awareness Month to shine light on condition

Date: 11/2/2017

GREATER SPRINGFIELD – Nov. 1 launched the inaugural Hyperhidrosis (Hh) Awareness Month. Why? Because the more people who know about Hh (excessive sweating), the sooner there will be a cure.

 Hyperhidrosis is not a cosmetic problem, a weather-related problem, a hormone problem, an anxiety problem, a weight problem, an exercise problem, a drug problem, or a personality problem. It’s a common, medical, serious, life-damaging, under-recognized and under-cared-for problem, and the International Hyperhidrosis Society wants everyone to know it.

Follow the International Hyperhidrosis Society on Facebook and Twitter during the entire month of November for give-aways, to learn useful Hh life hacks, and to help raise awareness about how life-altering and under-treated excessive sweating can be.

Hyperhidrosis Awareness Month will help to:
• Raise awareness about how common Hh actually is (nearly 5 percent of the population is affected and 17 percent of teenagers);
• Celebrate the resilience of those living with Hh;
• Share tips, support and hope; and
• Advocate for new, effective treatments.

Hyperhidrosis is often isolating. But it doesn’t have to be. Hyperhidrosis Awareness Month can help people with hyperhidrosis find more support and share their stories so that excessive sweating can be taken seriously and given the research and treatment development it deserves.

Pay special attention on Nov. 13 when the International Hyperhidrosis Society hosts an important Patient-Focused Drug Development (PFDD) meeting in Washington D.C. – giving individuals with hyperhidrosis a unique and powerful platform to share perspectives on the impacts of Hh and the treatments that are needed. People concerned about hyperhidrosis can register to be among 300 live webcast PFDD attendees and make their voices heard during the open comment period that opens November 13th at 1pm EST. Visit SweatHelp.org for more information.

Representatives from the FDA and key treatment developers will attend the PFDD and the commenting period will lead to public reports for future FDA and drug-developer awareness building, advocacy, and research.

Spread the word by using the hashtags #HhAwarenessMonth and #ActionForACure.

Visit www.SweatHelp.org for more information.